Abstract
A series of novel imidazolyl derivatives of fully and partially hydrogenated 1,8-acridinediones were synthesized and assessed for their cytotoxic activity on four different human cancer cell lines (HeLa, MCF-7, LS-180, and Raji cells). Although being inactive on LS-180 and Raji cell lines, the compounds showed weak to moderate anti-tumor activities on other cell lines and their IC50 ranged from 31.7 to more than 100 μM. Among the synthesized compounds 12b, 13b, 12c and 13c, bearing an electronattracting substituent on the imidazole ring, and 12f and 13f, with a benzyl substituent, showed higher activities. Furthermore, the calcium channel antagonist activity of the derivatives, an undesired effect when these compounds are used as anti-tumor agents, was much lower than that of Nifedipine, a reference antagonist. Imidazolyl derivatives of 1,8-acridinedione represent an interesting template, showing promising biological properties. Further investigation on this chemical scaffold could potentially lead to the discovery of cytotoxic agents with low calcium channel blocking activity.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
D.J. Triggle, Mini Rev. Med. Chem. 3 (2003) 215
A.M. Katz, N.M. Leach, J. Clin. Pharmacol. 27 (1987) 825
A. Davood, N. Mansouri, A.R. Dehpour, H. Shafaroudi, Arch. Pharm. Chem. Life Sci. 339 (2006) 299
A. Shafiee, N. Rastkary, M. Jorjani, B. Shafaghi, Arch. Pharm. 2 (2002) 69
A. Shafiee, N. Rastkary, M. Jorjani, Arzneim. Forsch./Drug Res. 52 (2002) 537
N. Daryabari, T. Akbarzadeh, M. Amini, R. Miri, H. Mirkhani, A. Shafiee, J. Iran. Chem. Soc. 4 (2007) 30
R. Miri, A.R. Dehpour, M. Azimi, A. Shafiee, DARU 9 (2001) 40.
F. Fusi, S. Saponara, M. Valoti, S. Dragoni, Curr. Drug Targets 7 (2006) 949
L. Bazargan, S. Fouladdel, A. Shafiee, M. Amini, Cell Biol. Toxicol. 24 (2008) 165
R. Miri, A.R. Mehdipour, Bioorg. Med. Chem. 16 (2008) 8329.
K.A. Hahn, A.M. Legendre, H.M. Schuller, J. Cancer Res. Clin. Oncol. 123 (1997) 34.
S.R. Morshed, K. Hashimoto, Y. Murotani, M. Kawase, Anticancer Res. 25 (2005) 2033.
L. Fedeli, M. Colozza, E. Boschetti, I. Sabalich, Cancer 6 (1989) 1805.
J. Jiang, J. Yu, X.X. Sun, Q.Q. Rao, L.Z. Gong, Angew. Chem. Int. Ed. 47 (2008) 2458.
C.O. Kappe, W.M.F. Fabian, M.A. Semones, Tetrahedron 53 (1997) 2803.
D.J. Triggle, Cell Mol. Neurobiol. 23 (2003) 293.
M. Schramm, G. Thomas, R. Tower, G. Franckowiak, Nature 303 (1983) 535.
K. Palani, P. Ambalavanan, M.N. Ponnuswamy, P. Murugan, V.T. Ramakrishnan, Cryst. Res. 40 (2005) 277.
S.J. Tu, Q. Wang, J.P. Zhang, X.T. Zhu, J.N. Xu, Acta Cryst. E61 (2005) 3743.
S.A. Pandi, D. Velmurugan, M.M. Govind, M.J. Kim, T. Josephrajan, Cryst. Res. Technol. 37 (2002) 293
K. Palani, D. Thirumalai, P. Ambalavanan, M.N. Ponnuswamy, V.T. Ramakrishnan, J. Chem. Cryst. 35 (2005) 751
P. Murugan, K.C. Hwang, V.T. Ramakrishnan, S. Balasubramanian, J. Materials online 1 (2005)1
H. Gao, W.A. Denny, R. Grag, C. Hansch, Chemico. Biol. Interact. 116 (1998) 157
A. Rajendran, B.U. Nair, Biochimica et Biophysica Acta 1760 (2006) 1794.
J. Konopa, Pure Appl. Chem. 73 (2001) 1421.
L. Araki, S. Harusawa, M. Yamaguchi, S. Yonezawa, N. Taniguchi, D.M.J. Lilley, Z. Zhaob, T. Kurihara, Tetrahedron 61 (2005) 11976.
P. Murugan, K.C. Hwang, D. Thirumalai, V.T. Ramakrishnan, Synthetic Commun. 35 (2005) 1781.
N. Srividya, P. Ramamurthy, P. Shanmugasundaram, V.T. Ramakrishnan, J. Org. Chem. 61 (1996) 5083.
M.K. Khan, G.M. Maharvi, M.T.H. Khan, A.J. Sheikh, S. Perveen, S. Begum, M.I. Choudhary, Bioorg. Med. Chem. 4 (2006) 344.
M. Amini, A.A. Golabchifar, H.R. Dehpour, M. Pirali, A. Shafiee, Arzneim-Forsch./Drug Res. 52 (2002) 21.
G.W. Wang, C.B. Miao, Green Chem. 8 (2006) 1080.
W. Guan-Wu, Bull. Chem. Soc. JPN. 79 (2006) 454.
S.J. Tu, B. Jiang, J.Y. Zhang, R. Jia, Y. Zhang, C.S. Yao, Org. Biomol. Chem. 4 (2006) 3980.
M. Nasr-Esfahani, M. Moghadam, G. Valipour, J. Iran. Chem. Soc. 2 (2008) 244.
A.R. Momeni, T. Sameh, H. Golmohammadi, H. Javaherian Naghash, H. Aliyan, A.R. Massah, S. Solati, Bull. Korean Chem. Soc. 27 (2006) 355.
V.J. Eynde, R. D’Orazio, Y.V. Haverbeke, Tetrahedron 50 (1994) 2479.
J.J.V. Eynde, A. Mayence, A. Maquestiau, Tetrahedron 48 (1992) 463.
H.R. Memarian, M. Abdoli-Senejani, S. Tangestaninejad, J. Iran. Chem. Soc. 3 (2006) 285.
P. Salehi, M.A. Zolfigol, F. Shirin, M. Baghbanzadeh, Current Org. Chem. 10 (2006) 2171.
R. Miri, H. Niknahad, G. Vesal, A. Shafiee, IL Framaco 57 (2002) 123.
A.R. Mehdipour, K. Javidnia, B. Hemmatinejad, Z. Amirghofran, R. Miri, Chem. Biol. Drug Des. 70 (2007) 337.
N. Daryabari, T. Akbarzadeh, M. Amini, R. Miri, H. Mirkhani, A. Shafiee, J. Iran. Chem. Soc. 1 (2007) 30.
B. Hemmateenejad, R. Miri, N. Edraki, M. Khoshneviszadeh, A. Shafiee, J. Iran. Chem. Soc. 4 (2007) 182.
R. Miri, K. Javidnia, B. Hemmateenejad, A. Azarpira, Z. Amirghofran, Bioorg. Med. Chem. 12 (2004) 2529.
S.A.B. Jabbar, P.R. Twentyman, J.V.Watson, Br. J. Cancer. 60 (1989) 523.
R.J. Taharida, R.B. Murray, in: R.J. Tallarida, R.B. Murry (Eds.), Manual of Pharmacologic Calculations, Springer-Verlag, New York, 1987.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jamalian, A., Miri, R., Firuzi, O. et al. Synthesis, cytotoxicity and calcium antagonist activity of novel imidazolyl derivatives of 1,8-acridinediones. JICS 8, 983–991 (2011). https://doi.org/10.1007/BF03246554
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03246554